Phase II study of oral S-1 plus oral leucovorin in patients with previously treated non-small-cell lung cancer

Phase II study of oral S-1 plus oral leucovorin in patients with previously treated non-small-cell lung cancer - Oral S-1 with leucovorin in non-small cell lung cancer

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000004568

Enrollment

Registered

2010-11-16

Start date

2010-12-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pre-treated non-small cell lung cancer

Interventions

Oral S-1 with leucovorin

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients with measurable disease and good performance status

Exclusion criteria

Exclusion criteria: patients with symptomatic brain metastasis

Design outcomes

Primary

Measure	Time frame
response rate	—

Secondary

Measure	Time frame
Safety, overall survival, progression free survival, and 1-year survival	—

Countries

Japan

Contacts

Public ContactMegumi Isii

Pharma Valley Center Clinical trial center

rinsho@fuji-pvc.jp055-980-6322

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026